A new phenanthroline–oxazine ligand: synthesis, coordination chemistry and atypical DNA binding interaction by McCann, Malachy et al.
This journal is c The Royal Society of Chemistry 2013 Chem. Commun., 2013, 49, 2341--2343 2341
Cite this: Chem. Commun.,2013,
49, 2341
A new phenanthroline–oxazine ligand: synthesis,
coordination chemistry and atypical DNA binding
interaction†
Malachy McCann,*a John McGinley,a Kaijie Ni,a Mark O’Connor,a Kevin Kavanagh,b
Vickie McKee,c John Colleran,d Michael Devereux,d Nicholas Gathergood,e
Niall Barron,e Andreea Prisecarue and Andrew Kellett*e
1,10-Phenanthroline-5,6-dione and L-tyrosine methyl ester react to
form phenanthroline–oxazine (PDT) from which [Cu(PDT)2](ClO4)2
and [Ag(PDT)2]ClO42MeOH are obtained. Binding to calf-thymus
DNAbyAg(I) and Cu(II) PDTcomplexes exceed bis-1,10-phenanthroline
analogues and the minor groove binding drugs, pentamidine and
netropsin. Furthermore, unlike the artificial metallonuclease,
[Cu(phen)2]
2+, the [Cu(PDT)2]
2+ complex does not cleave DNA in the
presence of added reductant indicating unique interaction with DNA.
1,10-Phenanthroline (phen), its organic derivatives and the plethora
of metal complexes containing theseN,N’-chelating heterocycles, find
use as optical devices,1,2 catalysts3 and as integral components of
supramolecular structures.4 In addition, these compounds have
found application in the biological field as antimicrobial and anti-
cancer agents,5 DNA intercalators,6 and as nucleoside constituents for
incorporation into the DNA backbone.7
The quest to make new and tailored phenanthrolines is ongoing,
and methods include synthesising the bases from elementary
building blocks1,8 and extending existing, functionalised phenan-
throlines.1 In the latter context, the quinone, 1,10-phenanthroline-
5,6-dione (phendio), has been used as the starting material for
grafting appendages onto the phenanthroline framework, via simple
Schiff base condensation reactions with primary amines.7,9–14 How-
ever, not all reactions of phendio with primary amines have resulted
in the expected Schiff base product. For example, combining
phendio with urea15 and N,N0-bis(2-aminophenyl)ethylenediamine16
unexpectedly produced a glycoluril and a gem-cis-bis(aminal),
respectively.
Generally, phendio and its Ag(I) and Cu(II) complexes are con-
siderably more biologically active than phen and its corresponding
metal complexes.5a,b With this in mind, we sought to improve
biological activity, selectivity and compatibility by attempting to
prepare a double Schiff base, phen-type ligand by reacting phendio
with two equivalents of (S)-methyl 2-amino-3-(4-hydroxyphenyl)-
propanoate (L-tyrosine methyl ester).
Phendio was initially treated with L-tyrosine methyl ester
(1 : 2 mol ratio) in anticipation of forming a double Schiff base
condensation product (Scheme 1). Unexpectedly, this combination
produced 1,10-phenanthroline-5,6-diol and a relatively low yield
of the new orange-yellow tetracyclic oxazine, PDT. The structure of
PDTMeOH (Fig. 1) showed that chirality within the compound is
retained, with C13 being the stereogenic centre (originally it was
C20). The molecule crystallises in the centrosymmetric space group,
P21/c, and so is a racemic mixture. Interestingly, the phenol ring is
almost orthogonal to the oxazine ring (bond angle 89.12(2)1) forming
a ‘chair’ profile. The pdtme molecules are linked into zig-zag chains
via hydrogen bonding through the methanol solvate; the phenol
group makes a H-bond to the oxygen of the methanol (2.6288(18) Å),
and the methanol OHmakes an unsymmetric, bifurcated H-bond to
the phenanthroline nitrogen atoms of a second molecule (3.028(2)
and 2.907(2) Å to N1 and N2, respectively, under symmetry operation
x + 2, y  1/2, z + 3/2).
What is themechanismof the cyclization reaction that leads to the
formation of the oxazine ring in pdtme? In their paper on the
oxidation of a-amino acids by quinones, Lourak and co-workers17
obtained cyclic derivatives containing oxazine rings. These researchers
Scheme 1 Proposed reaction mechanism of phendio with L-tyrosine methyl
ester leading to the formation of PDT.
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proposed a mechanism for their reaction in which a second
quinine molecule acted as a dehydrogenating agent to give the
cyclic product. In the present work, the isolation of 1,10-phenan-
throline-5,6-diol as a by-product of the reaction suggested that
reduction of some phendio was occurring as part of the reaction
mechanism. A likely first step is the formation of a Schiff base
(molecule A in Scheme 1). A plausible, concerted mechanism
for formation of the oxazine ring is offered in Scheme 1 and
involves the participation of a second phendio molecule as a
dehydrogenating agent. Due to steric restraints, resulting from
both A and phendio, this reaction is expected to be slow, as was
observed.
Interestingly, in the preparation of the phendio-amino acid ternary
complexes, [Cu(phendio)(L-Phe)(H2O)]ClO4H2O and [Ni(phendio)-
(Gly)(H2O)]ClO4H2O (L-PheH = L-phenylalanine, GlyH = glycine),
no interaction between the phendio carbonyl functions and the
amine group of the amino acid was reported.18 Reaction of PDT
with AgClO4 in a ca. 2 : 1 molar ratio gave the green solid,
[Ag(PDT)2]ClO42MeOH (AgPDT), in good yield. The complex
cation, [Ag(PDT)2]
+, is thought to be essentially isostructural
with the cation in the structurally characterised complex,
[Ag(phendio)2]ClO4,
19 where the metal has approximately tetra-
hedral geometry. In comparison to the 1H NMR spectrum of
metal-free PDT, the spectrum of AgPDT showed shifts in the
signals associated with the phen part of the pdtme molecule
rather than the ester part of the molecule, indicating that the Ag+
ion is chelated by the two nitrogen atoms. In a similar reaction
using Cu(ClO4)26H2O, the green solid, [Cu(PDT)2](ClO4)2
(CuPDT), was obtained in moderate yield. Again, it is believed
that [Cu(PDT)2]
2+ is structurally similar to the known tetrahedral
cation in [Cu(phen)2](ClO4)2 (CuPhen).
20
In an effort to establish how the metal-free PDT ligand and its
Cu(II) and Ag(I) complexes interact with DNA four distinct assays
were conducted. To establish an apparent DNA binding constant
(Kapp) a sample of high-purity calf thymus (CT) DNA is firstly treated
with an excess of EtBr and then this highly fluorescent, Et+-saturated
DNA sample is exposed to a range of concentrations of the
competitor test compound. A reduction in fluorescence indicates
ejection of the bound Et+ from the DNA backbone and replacement
by the test species. Samples are compared based on their Kapp
values, which are calculated from the concentration of sample
required to accomplish a 50% reduction of the initial fluorescence
(Fig. 2 and Table 1). Metal-free PDT, phen and the simplemetal salts
all showed considerably less DNA binding affinities than AgPDT
and CuPDT, which have almost identical Kapp values. The Ag(I) and
Cu(II) PDT complexes also showed a higher binding capacity than
the known groove-binding drugs, pentamidine and netropsin.
The binding of metal-free PDT to DNA is significantly stronger than
that of metal-free phen, suggesting that the additional functional-
ities on the backbone provide secondary binding interactions with
the nucleic acid. The contribution of these extra interactions is also
apparent when the binding constants of PDT and phen metal
complexes are compared (Kapp for AgPDT is B3 times larger than
AgPhen and CuPDT isB11 times that of CuPhen).
Competitive displacement of DNA-bound Hoechst 33258 (minor
groove binder) and ethidium cations (Et+, intercalator) was assessed
using fluorescence quenching, which utilises an unsaturated dye–
DNA combination in which a limited number of binding spaces on
the DNA polymer are occupied at any one time by the interacting dye,
which strongly fluoresces once boundwith a relatively high number of
unoccupied sites remaining for test compound interaction. The
introduction of a new compound to the DNA may then displace
Hoechst or Et+ either directly or indirectly (i.e. through a conforma-
tional change which results in dye ejection) and can give valuable
information regarding a binding interaction mode,21 although, cau-
tion must be exercised here considering the binding constant and
binding stoichiometry of ethidium bromide and Hoechst to CT-DNA.
The minor groove binders, pentamidine and netropsin, displayed
high quenching affinity (Q) for Hoechst 33258 bound DNA and were,
as expected, an order ofmagnitude less effective in their quenching of
ethidium (Table 1). Both AgPhen and CuPhen displayed higher Q
values toward Et+ than compared with Hoechst. Interestingly, both
AgPDT and CuPDT displayed higher Q values, along with different
profiles,† and were almost identical in their ejection of bound
Hoechst and Et+. From these quenching data it is evident that the
Fig. 1 Space-fill view of pdtme in PDTMeOH (MeOH shown in stick view) (left),
and a view of PDTMeOH with 50% ADPs (right).
Fig. 2 Competitive EtBr displacement with CT-DNA (left) and DNA cleavage reactions
of pBR322 plasmid DNA (400 ng) with 1 mM Na-L-ascorbate analysed on agarose gel
electrophoresis (right). Lane 1: DNA control; lane 2: [Cu(OAc)2]; lane 3: AgNO3; lane 4:
PDT; lane 5: CuPhen; lane 6: AgPhen; lane 7: CuPDT; lane 8: AgPDT.
Table 1 Apparent DNA binding constants (Kapp) of the test compounds and
fluorescence quenching (Q) values
Compound C50
a (mM) Kapp
b
Qc Hoechst
33258 (mM)
Qc Ethidium
bromide (mM)
Pentamidine 109.41 1.09  106 35.86 >150
Netropsin 39.99 4.77  106 3.50 35.98
AgPDT 15.75 7.60  106 24.65 18.18
CuPDT 15.70 7.62  106 18.00 18.59
AgPhen 45.01 2.65  106 45.54 27.90
CuPhen 179.21 6.67  105 34.96 20.38
1,10-Phen >300 N/A — —
PDT 247.21 4.80  105 — —
AgClO4 >300 N/A — —
[Cu(OAc)2] >300 N/A — —
a C50 = concentration required to reduce fluorescence by 50%.
b Kapp =
Ke  12.6/C50 where Ke = 9.5  106 M(bp)1; N/A = not available. c Q =
reduction of 50% initial fluorescence from DNA-bound dye.
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PDT complexes have significantly higher binding affinities (Kapp) and
an alternate binding mode compared with their bis-phen analogues.
Viscosity experiments were conducted using salmon testes
dsDNA (1 mM in DNAp) (Fig. 3).† Intercalating agents
(e.g. ethidium) are known to increase viscosity which results
from a conformational change induced after accommodation
between DNA bases, while surface binding species (e.g. netrop-
sin) can typically have only a moderate or diminished effect on
viscosity. This expected pattern emerged during our analysis of
both these standard agents (Fig. 3). It was also evident that
CuPhen, containing the [Cu(phen)2]
2+ cation, produced an
intercalative profile while, significantly, CuPDT did not appear
to intercalate DNA but had a profile similar to the surface
binding drugs, netropsin and pentamide. Furthermore, the
viscosity profile for CuPDT was distinctive from that of the
partial intercalating mono-phen complex, [Cu(phen)]2+.
Relaxation of supercoiled pBR322 (Form I) into open circular
(Form II) and linear (Form III) conformations was used to quantify
the relative DNA cleavage efficiency (nuclease activity) of the test
complexes. DNA cleavage by [Cu(phen)2]
2+ is known to be dependent
on the presence of added oxidant and/or reductant, and the assay was
conducted in an aerobic environment (O2 oxidant) along with the
addition of a 1 mM solution of the reductant, sodium L-ascorbate.
Samples (5 mM) were incubated for 30 min at 37 1C before being
quenched and analysed using gel electrophoreses. The only complex
found to be active (Fig. 2) was the known chemical nuclease,
[Cu(phen)2]
2+.22 This dication renders almost complete degradation
of Form I to linear Form III by interacting at the surface of the minor
groove of DNA and in the presence of a reductant, which can gain
access to the Cu(II) centre in the complex, DNA oxidation occurs
predominantly in this region. It was somewhat surprising thatCuPDT
was almost inactive compared with [Cu(phen)2]
2+. Furthermore, any
role that the phenol moiety in PDT may play in scavenging free
radicals to prevent DNA damage looks quite unlikely as CuPhen,
incubated with up to 100 mM of phenol, produced only a marginal
inhibition of pBR322 cleavage (Fig. S3).†
The redox behaviour of CuPhen and CuPDT was investigated,
using cyclic voltammetry, to shed light on the observed differences
in their efficacy as DNA nuclease agents (Fig. 3 and Fig. S4–S9).†
The Cu(II)/Cu(I) redox couple was centred around 0.46 and
0.39 V for CuPhen and CuPDT, respectively. Addition of 2 mM
ascorbate results in a significant anodic shift in the Cu(II)/Cu(I)
redox couple of both complexes, indicative of a more facile electron
transfer regime. The original Cu(II) reduction peak for CuPhen is
observed at 0.47 V but, interestingly, is not evident at scan
rates r40 mV s1, which suggests a transient species. While
CuPhen tends toward reversibility in the presence of ascorbate
(DEP = 65 mV), CuPDT remains quasi-reversible (DEP = 119 mV,
Table S1, ESI†). Thus, the reversibility of the Cu2+/Cu+ couple may
justify the greater DNA cleavage ability of CuPhen.
For concluding remarks please see ESI.†
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